EP 36 Genomics England CEO Chris Wigley & Clinical Lead Richard Scott: sequencing 35,000 people with COVID19, the future of genomic medicine, and why patients are their 'north star'
May 27th, 2020 | 25 mins 18 secs
coronavirus, covid19, genetics, genomics england
Why do some people have a severe response to COVID-19, and others seem to have no symptoms at all? Is the answer in our genes?
This week we talk to Chris Wigley, the CEO of Genomics England and Interim SRO for Data-NHSX, and Dr Richard Scott, the clinical lead for rare disease at Genomics England and consultant clinical geneticist at Great Ormond Street.
If you would like to volunteer for Genomics England's study on COVID19, sign up here: https://www.genomicsengland.co.uk/covid-19/